Back to Search

MARY PADILLA

Peer Specialist

NPI: 1326571704Individual

Specialties, Licenses & Credentials

Peer SpecialistPrimary

Peer Specialist

Code: 175T00000X

MPSS-0K0JHF(CA)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
0
With Results

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (1)

Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.
PMID 40216412·BMJ Open Respir Res·2025
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
302 CHERRY LN
MANTECA, CA 95337

Quick Facts

NPI
1326571704
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
1
Publications
1

Are you this provider?

Claim Your Profile